AAIC 2025 Symposium
Session agenda
Inhibition of β-amyloid Oligomer Neurotoxicity with Oral Valiltramiprosate
| Dr. Cohen [00:00] | Chair’s Welcome & Program Objectives |
| Dr. Gandy [07:42] | Pathogenic Role of Beta Amyloid Oligomers in AD |
| Dr. Ono [20:20] | Insights into Mechanism of Action of Valiltramiprosate |
| Dr. Geerts [34:35] | QSP Analysis of Inhibition of Amyloid Oligomer Formation by Valiltramiprosate |
| Dr. Hey [45:45] | Disease Modifying Effects of Valiltramiprosate in Early Symptomatic AD |
| Dr. Cohen [1:03:20] | Questions & Answers |
For privacy reasons Vimeo needs your permission to be loaded. For more details, please see our Privacy Policy.
